David Cetlin

Latest from David Cetlin

Using Retrovirus-Like Particles for Downstream Viral-Clearance Evaluation: Implications of the 2022 ICH Q5A Revision
Sponsored Content
Using Retrovirus-Like Particles for Downstream Viral-Clearance Evaluation: Implications of the 2022 ICH Q5A RevisionUsing Retrovirus-Like Particles for Downstream Viral-Clearance Evaluation: Implications of the 2022 ICH Q5A Revision
byDavid Cetlin
Nov 16, 2023
Antibody Therapeutic Polishing: Utility of Hydrophobic-Interaction Chromatography
Sponsored Content
Antibody Therapeutic Polishing: Utility of Hydrophobic-Interaction ChromatographyAntibody Therapeutic Polishing: Utility of Hydrophobic-Interaction Chromatography
byJohn J. Li, Moira Lynchand 1 more
Oct 5, 2023

All from David Cetlin

Viral Clearance in the Age of Q5A(R2) and the Case for Using Noninfectious Spiking Agents
Sponsored Content
Viral Clearance in the Age of Q5A(R2) and the Case for Using Noninfectious Spiking Agents
Viral Clearance in the Age of Q5A(R2) and the Case for Using Noninfectious Spiking Agents
Sep 14, 2023
byDavid Cetlin, Alla Zilberman
Using CHO-Endogenous RVLPs for Retroviral Clearance Studies
Sponsored Content
Using CHO-Endogenous RVLPs for Retroviral Clearance Studies
Using CHO-Endogenous RVLPs for Retroviral Clearance Studies
Jun 26, 2023
byDavid Cetlin, Alla Zilberman
Predicting Viral Clearance in Downstream Process Development
Sponsored Content
Predicting Viral Clearance in Downstream Process Development
Predicting Viral Clearance in Downstream Process Development
May 27, 2021
byDavid Cetlin
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Viral Clearance
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Viral Clearance in a Downstream AAV Process: Case Study Using a Model Virus Panel and a Noninfectious Surrogate
Apr 16, 2021
+12
byMichael Winkler, Mikhail Goldfarband 12 more
Predicting Viral Clearance at Your Benchtop
Sponsored Content
Predicting Viral Clearance at Your Benchtop
Predicting Viral Clearance at Your Benchtop
Aug 10, 2020
byDavid Cetlin
Monoclonal Antibody Aggregate Polish and Viral Clearance Using Hydrophobic-Interaction Chromatography
Sponsored Content
Monoclonal Antibody Aggregate Polish and Viral Clearance Using Hydrophobic-Interaction Chromatography
Monoclonal Antibody Aggregate Polish and Viral Clearance Using Hydrophobic-Interaction Chromatography
Dec 16, 2019
+1
byDavid Cetlin, Moira Lynchand 1 more
Modeling Virus Clearance: Use of a Noninfectious Surrogate of Mouse Minute Virus As a Tool for Evaluating an Anion-Exchange Chromatography Method
Viral Clearance
Modeling Virus Clearance: Use of a Noninfectious Surrogate of Mouse Minute Virus As a Tool for Evaluating an Anion-Exchange Chromatography Method
Modeling Virus Clearance: Use of a Noninfectious Surrogate of Mouse Minute Virus As a Tool for Evaluating an Anion-Exchange Chromatography Method
May 17, 2019
+4
byKevin Herbig, David Cetlinand 4 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024